What this test measures
This test measures IgM-class antibodies against β2 glycoprotein 1 — a plasma protein that the immune system targets in antiphospholipid syndrome (APS). IgM antibodies often appear earlier in autoimmune activation, can fluctuate, and are less specific for APS than the IgG class. Both isotypes are reported alongside anti-cardiolipin and lupus anticoagulant.
The 2023 ACR/EULAR classification criteria assign more weight to IgG than to IgM antibodies; persistent moderate-to-high IgM still contributes to APS classification, particularly with obstetric morbidity.
Why it matters
A positive anti-β2GPI IgM, when persistent on testing 12 weeks apart, supports APS — especially in patients with recurrent early pregnancy loss, late stillbirth, severe early pre-eclampsia, or unexplained venous thrombosis. A transient IgM positive can occur with infection, autoimmune flare, or drug exposure, so confirmation is essential before any change in treatment.
In Indian obstetric and rheumatology practice the full APS panel (lupus anticoagulant + anti-cardiolipin IgG/IgM + anti-β2GPI IgG/IgM) is checked together because each test contributes differently and "triple positive" patients have the highest event risk.
How to prepare
No fasting required. Stop biotin supplements at least 48 hours before testing — biotin interferes with several immunoassays. Disclose recent infection (can cause transient positive results), pregnancy status, and any anticoagulant medication. Plan for a repeat sample at least 12 weeks later to confirm persistent positivity.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| Anti-β2 Glycoprotein 1 IgM (U/mL (MPL-U))[1][2][3] | Negative — assay-specific (often < 20 MPL-U) | Negative: does not support APS at the time of sampling. Repeat after 12 weeks if clinical suspicion is high. | 20 – 40 U: low positive — uncertain clinical significance, repeat in 12 weeks. > 40 U: medium-to-high positive — significant titer, requires repeat in 12 weeks to confirm persistence. Persistent high-positive IgM with qualifying clinical events supports APS classification, though IgG carries more weight in current criteria. |
IgG vs IgM in antiphospholipid antibody testing
| Aspect | IgG | IgM |
|---|---|---|
| Appearance after exposure | Later, persistent | Earlier, more variable |
| Specificity for APS | Higher | Lower (more transient positives) |
| Diagnostic weight (2023 ACR/EULAR) | Higher | Lower but still counts |
| Clinical use | Thrombosis + obstetric APS | Mostly obstetric APS |
Frequently asked questions
Is IgM enough to diagnose APS?
On its own, an isolated IgM positive carries less diagnostic weight than IgG. APS is diagnosed when persistent (≥12 weeks apart) moderate-to-high antibody is combined with a qualifying clinical event (thrombosis or specific pregnancy morbidity).
Why is the test repeated in 12 weeks?
Transient antiphospholipid antibodies can appear after infections (HIV, hepatitis C, EBV, syphilis), with certain medications, or during acute illness. APS classification requires persistent positivity on two samples ≥12 weeks apart.
Can I have APS without symptoms?
Persistent antibodies without a clinical event are called "asymptomatic carriers". Not all develop APS, but they have higher long-term risk. Low-dose aspirin is sometimes considered after individualised risk assessment, especially in triple-positive carriers.
How is APS treated in pregnancy?
Standard regimen is low-dose aspirin (started preconception or at confirmation of pregnancy) plus low-molecular-weight heparin (started after positive pregnancy test). Close obstetric and rheumatology monitoring is essential.
Will biotin affect my result?
Yes — biotin (B7) supplements in doses ≥ 5 mg/day can interfere with many immunoassays including β2GPI assays. Stop biotin at least 48 hours before testing and tell the lab if you have taken it recently.
Does a recent infection affect the test?
Yes — viral infections and even routine bacterial infections can produce transient antiphospholipid antibodies, especially IgM. Defer testing to a stable, well period where possible, and always repeat in 12 weeks.
Related Immunology tests
Tests commonly ordered alongside BETA 2 GLYCOPROTEIN 1 - IGM, or that help interpret an unexpected result.
Sources & references
- NCBI StatPearls — Antiphospholipid Syndrome · accessed 2026-05-30T00:00:00.000Z
- ACR/EULAR 2023 APS Classification Criteria · accessed 2026-05-30T00:00:00.000Z
- Mayo Clinic Labs — Beta-2 Glycoprotein I Antibodies · accessed 2026-05-30T00:00:00.000Z
- NIH MedlinePlus — Antiphospholipid Antibody Syndrome · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your BETA 2 GLYCOPROTEIN 1 - IGM test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book BETA 2 GLYCOPROTEIN 1 - IGM now